Profil

FRIPPIAT Frédéric

Département de médecine interne > Service des maladies infectieuses - médecine interne

See author's contact details
ORCID
0000-0003-3891-8864
Main Referenced Co-authors
Moutschen, Michel  (29)
Léonard, Philippe  (26)
Giot, Jean-Baptiste  (19)
Meuris, Christelle  (16)
Layios, Nathalie  (13)
Main Referenced Keywords
Humans (15); Male (5); Aged (3); Middle Aged (3); Continuous infusion (2);
Main Referenced Unit & Research Centers
d‐BRU - Dental Biomaterials Research Unit - ULiège [BE] (1)
Main Referenced Disciplines
Immunology & infectious disease (41)
Anesthesia & intensive care (9)
Pharmacy, pharmacology & toxicology (9)
General & internal medicine (6)
Cardiovascular & respiratory systems (4)

Publications (total 71)

The most downloaded
944 downloads
Deleixhe, B., FRIPPIAT, F., Léonard, P., WITHOFS, N., MEEX, C., Pierard, L., & Moutschen, M. (2017). Endocardite à aggregatibacter aphrophilus sur prothèses valvulaires. Revue Médicale de Liège, 72 (12), 522-528. https://hdl.handle.net/2268/234164

The most cited

487 citations (Scopus®)

Niemi, M., Gazon, H., JUSZCZAK, D., FADEUR, M., CAMBY, S., MEURIS, C., THYS, M., JACQUES, J., HENKET, M., BEGUIN, Y., Rahmouni, S., Lebrun, M., MOUTSCHEN, M., Misset, B., DARCIS, G., GUIOT, J., AZARZAR, S., DELLOT, P., GOFFLOT, S., ... HUYNEN, P. (Other coll.). (2021). Mapping the human genetic architecture of COVID-19. Nature, 600, 472-477. doi:10.1038/s41586-021-03767-x https://hdl.handle.net/2268/260539

Bayoudh, F., Giot, J.-B., Descy, J., Fontaine, C., Hayette, M.-P., Baron, F., WILLEMS, E., Beguin, Y., FRIPPIAT, F., & Servais, S. (March 2024). Oral minocycline as systemic therapy for uncomplicated venous access device-related bloodstream infection with coagulase-negative staphylococci after allogeneic hematopoietic cell transplantation. Current Research in Translational Medicine, 72 (1), 103422. doi:10.1016/j.retram.2023.103422
Peer Reviewed verified by ORBi

El Moussaoui, M., Guiot, J., FRIPPIAT, F., & Darcis, G. (May 2023). Une cause émergente de fatigue et de douleurs chroniques : l’affection post-COVID-19 ou COVID long. Revue Médicale de Liège, 78 (5-6), 299 - 304.
Editorial Reviewed verified by ORBi

Pathak, G. A., Karjalainen, J., Stevens, C., Neale, B. M., Daly, M., Ganna, A., Andrews, S. J., Kanai, M., Cordioli, M., Polimanti, R., Harerimana, N., Pirinen, M., Liao, R. G., Chwialkowska, K., Trankiem, A., Balaconis, M. K., Nguyen, H., Solomonson, M., Veerapen, K., ... Baillie, J. K. (03 August 2022). A first update on mapping the human genetic architecture of COVID-19. Nature, 608, 1-E10. doi:10.1038/s41586-022-04826-7
Peer Reviewed verified by ORBi

Layios, N., Visée, C., Mistretta, V., Denooz, R., Maes, N., Descy, J., Frippiat, F., Marchand, S., & Grégoire, N. (2022). Modelled target attainment after temocillin treatment in severe pneumonia: systemic and epithelial lining fluid pharmacokinetics of continuous versus intermittent infusions. Antimicrobial Agents and Chemotherapy, 0205221. doi:10.1128/AAC.02052-21
Peer Reviewed verified by ORBi

Nakanishi, T., Pigazzini, S., Degenhardt, F., Cordioli, M., Butler-Laporte, G., Maya-Miles, D., Nafría-Jiménez, B., Bouysran, Y., Niemi, M., Palom, A., Ellinghaus, D., Khan, A., Martínez-Bueno, M., Rolker, S., Amitano, S., Tato, L. R., Fava, F., Spinner, C. D., Prati, D., ... consortium, C.-H. (October 2021). Age-dependent impact of the major common genetic risk factor for COVID-19 on severity and mortality. Journal of Clinical Investigation, Online ahead of print.. doi:10.1172/JCI152386
Peer Reviewed verified by ORBi

GONCETTE, V., Layios, N., DESCY, J., & FRIPPIAT, F. (September 2021). Continuous infusion, therapeutic drug monitoring and outpatient parenteral antimicrobial therapy with ceftazidime/avibactam: a retrospective cohort study. Journal of Global Antimicrobial Resistance, 26, 15 - 19. doi:10.1016/j.jgar.2021.04.015
Peer Reviewed verified by ORBi

Tchana-Sato, V., Hans, G., FRIPPIAT, F., ZEKHNINI, I., Dulgheru, R. E., Brüls, S., Durieux, R., LAVIGNE, J.-P., & Defraigne, J. (March 2021). Streptococcus agalactiae infective endocarditis: analysis of eight surgical cases from a single centre. Infectious Diseases, 53 (3), 189 - 195. doi:10.1080/23744235.2020.1863460
Peer Reviewed verified by ORBi

Plum, P.-E., Maes, N., Sauvage, A.-S., Frippiat, F., Meuris, C., Uurlings, F., Lecomte, M., Léonard, P., Paquot, N., Fombellida, K., Vaira, D., Moutschen, M., & Darcis, G. (2021). Impact of switch from tenofovir disoproxil fumarate-based regimens to tenofovir alafenamide-based regimens on lipid profile, weight gain and cardiovascular risk score in people living with HIV. BMC Infectious Diseases, 21 (1), 910. doi:10.1186/s12879-021-06479-9
Peer Reviewed verified by ORBi

Vercheval, C., Sadzot, B., MAES, N., Denooz, R., Damas, P., & FRIPPIAT, F. (2021). Continuous infusion of cefepime and neurotoxicity: a retrospective cohort study. Clinical Microbiology and Infection. doi:10.1016/j.cmi.2020.07.003
Peer Reviewed verified by ORBi

Niemi, M., Gazon, H., JUSZCZAK, D., FADEUR, M., CAMBY, S., MEURIS, C., THYS, M., JACQUES, J., HENKET, M., BEGUIN, Y., Rahmouni, S., Lebrun, M., MOUTSCHEN, M., Misset, B., DARCIS, G., GUIOT, J., AZARZAR, S., DELLOT, P., GOFFLOT, S., ... HUYNEN, P. (Other coll.). (2021). Mapping the human genetic architecture of COVID-19. Nature, 600, 472-477. doi:10.1038/s41586-021-03767-x
Peer Reviewed verified by ORBi

Meuris, C., Kremer, C., Geerinck, A., Locquet, M., Bruyère, O., Defêche, J., Meex, C., Hayette, M.-P., Duchene, L., Dellot, P., Azarzar, S., Maréchal, N., Sauvage, A.-S., Frippiat, F., Giot, J.-B., Léonard, P., Fombellida, K., Moutschen, M., Durkin, K., ... Darcis, G. (2021). Transmission of SARS-CoV-2 After COVID-19 Screening and Mitigation Measures for Primary School Children Attending School in Liège, Belgium. JAMA Network Open, 4 (10), 2128757. doi:10.1001/jamanetworkopen.2021.28757
Peer Reviewed verified by ORBi

Belche, J. L., Delree, G., Dessard, A., Crismer, A., Janssen, B., Spiers, S., Bolly, C., Meuris, C., GILLAIN, S., Berg, N., Frippiat, F., Bouckenaere, D., Desmedt, M., Vanhalewyn, M., Mary, Q., Adam, S., Giet, D., & Moreau, J.-F. (2020). Vademecum de prise en charge de patients COVID au sein d'institutions résidentielles. https://orbi.uliege.be/handle/2268/261134

GONCETTE, V., Layios, N., & Frippiat, F. (2020). Continuous infusion and outpatient parenteral antimicrobial therapy with ceftazidime-avibactam: evaluation of efficacy based on therapeutic drug monitoring [Paper presentation]. ECCMID 2020.
Peer reviewed

El Moussaoui, M., Lambert, I., MAES, N., SAUVAGE, A.-S., FRIPPIAT, F., MEURIS, C., UURLINGS, F., LECOMTE, M., LEONARD, P., Fombellida, K., VAIRA, D., Vercheval, C., Moutschen, M., & Darcis, G. (2020). Evolution of Drug Interactions With Antiretroviral Medication in People With HIV. Open Forum Infectious Diseases, 7 (11), 416. doi:10.1093/ofid/ofaa416
Peer Reviewed verified by ORBi

FRIPPIAT, F., Vercheval, C., & Layios, N. (2020). Meropenem: continuous or extended infusion? Critical care (London, England), 24 (1), 192. doi:10.1186/s13054-020-02883-w
Peer reviewed

Vercheval, C., DAMAS, P., & FRIPPIAT, F. (2020). Quality of documentation on antibiotic treatment in medical records: evaluation of the long-term impact of an antimicrobial stewardship intervention [Poster presentation]. 30th European Congress of Clinical Microbiology and Infectious Diseases (ECCMID), Paris, France.

Tajildin, R., MARCHETTA, S., FRIPPIAT, F., & Lancellotti, P. (2020). Endocardite infectieuse a Streptococcus agalactiae. Revue Médicale de Liège, 75 (2), 94-99.
Peer reviewed

TCHANA-SATO, V., HANS, G., FRIPPIAT, F., ZEKHNINI, I., DULGHERU, R. E., LAVIGNE, J.-P., & Defraigne, J.-O. (2020). surgical management of staphylococcus capitis prosthetic valve infective endocarditis: retrospective review of a 10 year single center experience and review of the literature. Journal of Infection and Public Health. doi:10.1016/j.jiph.2020.09.010
Peer Reviewed verified by ORBi

El Moussaoui, M., Lambert, I., MAES, N., SAUVAGE, A.-S., FRIPPIAT, F., MEURIS, C., UURLINGS, F., LECOMTE, M., LEONARD, P., FOMBELLIDA, K., VAIRA, D., Vercheval, C., MOUTSCHEN, M., & DARCIS, G. (22 November 2019). Evolution of drug interactions with antiretroviral medications in HIV-infected patients [Poster presentation]. 8th BREACH SYMPOSIUM, Liège, Belgium.

El Moussaoui, M., Lambert, I., MAES, N., SAUVAGE, A.-S., FRIPPIAT, F., MEURIS, C., UURLINGS, F., LECOMTE, M., LEONARD, P., Fombellida, K., VAIRA, D., Vercheval, C., MOUTSCHEN, M., & DARCIS, G. (08 November 2019). Evolution of drug interactions with antiretroviral medications in HIV-infected patients [Paper presentation]. 17th European AIDS Conference, Bâle, Switzerland.

Vercheval, C., GILLET, M., Koch, N., HAYETTE, M.-P., FRIPPIAT, F., DAMAS, P., & VAN HEES, T. (2019). Utilisation de la nystatine dans la candidose oropharyngée au CHU de Liège. Journal de Pharmacie de Belgique.
Peer Reviewed verified by ORBi

Pirotte, B., FRIPPIAT, F., DARCIS, G., Rassenfosse, M., Fombellida, K., MAES, N., Moerman, F., & MOUTSCHEN, M. (2019). Etude des motifs d'admission au service des Urgences d'une cohorte de patients. Revue Médicale de Liège.
Peer reviewed

DARCIS, G., MAES, N., Pasternak, A., SAUVAGE, A.-S., FRIPPIAT, F., MEURIS, C., UURLINGS, F., LECOMTE, M., LEONARD, P., El Moussaoui, M., Fombellida, K., VAIRA, D.* , & MOUTSCHEN, M.*. (2019). Detectability of HIV residual Viremia despite therapy is highly associated with treatment with a protease inhibitor-based combination antiretroviral therapy. Antimicrobial Agents and Chemotherapy. doi:10.1128/AAC.01902-19
Peer Reviewed verified by ORBi
* These authors have contributed equally to this work.

DARCIS, G., Lambert, I., SAUVAGE, A.-S., FRIPPIAT, F., MEURIS, C., UURLINGS, F., LECOMTE, M., LEONARD, P., GIOT, J.-B., fombellida, K., VAIRA, D., & MOUTSCHEN, M. (2018). Factors associated with late presentation for HIV care in a single Belgian reference center: 2006-2017. Scientific Reports. doi:10.1038/s41598-018-26852-0
Peer Reviewed verified by ORBi

DESCY, J., VISEE, C., FRIPPIAT, F., MEEX, C., LAYIOS, N., VAN BAMBEKE, F., & MELIN, P. (21 April 2018). Temocillin susceptibility testing with Vitek2® system and E-test® Are these methods reliable to determine temocillin MIC ? [Poster presentation]. ECCMID 2018.

HALLEUX, D., Juriens, I., Delwaide, J., FRIPPIAT, F., LEONARD, P., BLETARD, N., & DETRY, O. (February 2018). Prise en charge multidisciplinaire d'une volumineuse hydatidose hepatique. Revue Médicale de Liège, 73 (2), 65-71.
Peer reviewed

FRIPPIAT, F., Hayette, M.-P., & MEEX, C. (25 January 2018). L’approche syndromique : quel bénéfice pour le patient ? Application aux méningo-encéphalites [Paper presentation]. Formation continue en biologie clinique, LIEGE, Belgium.

MARCHETTA, S., DULGHERU, R. E., Oury, C., FRIPPIAT, F., & Lancellotti, P. (2018). Une urgence bien souvent meconnue. Revue Médicale de Liège, 73 (5-6), 283-289.
Peer reviewed

VISEE, C., LAYIOS, N., MISTRETTA, V., MAES, N., VAN BAMBEKE, F., & FRIPPIAT, F. (23 April 2017). Epithelial lining fluid penetration of temocillin administered by continuous infusion in critically ill patients with nosocomial pneumonia [Paper presentation]. 27th European Congress of Clinical Microbiology and Infectious Diseases (ECCMID), Vienne, Austria.

VISEE, C., FRIPPIAT, F., DESCY, J., MEEX, C., MELIN, P., MISTRETTA, V., VAN BAMBEKE, F., & LAYIOS, N. (22 April 2017). Are Vitek2 system and E-test relevant and reliable for determining susceptibility to temocillin? [Poster presentation]. 27th European Congress of Clinical Microbiology and Infectious Diseases (ECCMID), Vienne, Austria.

Kabore, C., FRIPPIAT, F., & GILLET, P. (2017). PRISE EN CHARGE DE L’OSTÉOMYÉLITE CHRONIQUE PAR ANTIBIOTHÉRAPIE SUPPRESSIVE AU LONG COURS. Revue Médicale de Liège.
Peer reviewed

Deleixhe, B., FRIPPIAT, F., Léonard, P., WITHOFS, N., MEEX, C., Pierard, L., & Moutschen, M. (2017). Endocardite à aggregatibacter aphrophilus sur prothèses valvulaires. Revue Médicale de Liège, 72 (12), 522-528.
Peer reviewed

FRIPPIAT, F., VERCHEVAL, C., & LAYIOS, N. (01 February 2016). Decreased antibiotic consumption in the Belgian community: Is it credible? Clinical Infectious Diseases, 62 (3), 403-404. doi:10.1093/cid/civ868
Peer Reviewed verified by ORBi

VERCHEVAL, C., GILLET, M., MAES, N., Albert, A., FRIPPIAT, F., Damas, P., & Van Hees, T. (2016). Quality of documentation on antibiotic therapy in medical records: evaluation of combined interventions in a teaching hospital by repeated point prevalence survey. European Journal of Clinical Microbiology and Infectious Diseases, 35 (9), 1495–1500. doi:10.1007/s10096-016-2690-0
Peer Reviewed verified by ORBi

DAMAS, P., FRIPPIAT, F., ANCION, A., CANIVET, J.-L., LAMBERMONT, B., LAYIOS, N., MASSION, P., MORIMONT, P., NYS, M., PIRET, S., LANCELLOTTI, P., WIESEN, P., D'ORIO, V., SAMALEA SUAREZ, N., & LEDOUX, D. (January 2015). Prevention of ventilator-associated pneumonia and ventilator-associated conditions: A randomized controlled trial with subglottic secretion suctioning. Critical Care Medicine, 43 (1), 22-30. doi:10.1097/CCM.0000000000000674
Peer Reviewed verified by ORBi

FRIPPIAT, F., Musuamba, F. T., Seidel, L., Albert, A., DENOOZ, R., Charlier, C., Van Bambeke, F., Wallemacq, P., DESCY, J., LAMBERMONT, B., LAYIOS, N., DAMAS, P., & Moutschen, M. (12 September 2014). Modelled target attainment after meropenem infusion in patients with severe nosocomial pneumonia: the PROMESSE study. Journal of Antimicrobial Chemotherapy, 70, 207-216. doi:10.1093/jac/dku354
Peer Reviewed verified by ORBi

Frippiat, F., Seidel, L., Denooz, R., DAMAS, P., Layios, N., & Moutschen, M. (2014). Pharmacokinetics of Extended vs Intermittent Intravenous Infusion of Meropenem in Critically Ill Patients Receiving Continuous Veno-Venous Haemofiltration. Open Forum Infectious Diseases. doi:10.1093/ofid/ofu052
Peer Reviewed verified by ORBi

KEUTGENS, A., SIMONI, P., DETREMBLEUR, N., FRIPPIAT, F., GIOT, J.-B., SPIRLET, F., AGHAZARIAN, S., DESCY, J., MEEX, C., HUYNEN, P., Melin, P., MULLER, N., GOTTSTEIN, B., CARLIER, Y., & Hayette, M.-P. (February 2013). FATAL ALVEOLAR ECHINOCOCCOSIS OF THE LUMBAR SPINE. Journal of Clinical Microbiology, 51 (2), 688-91. doi:10.1128/JCM.01906-12
Peer Reviewed verified by ORBi

FRIPPIAT, F., VERCHEVAL, C., LAMBERMONT, B., & DAMAS, P. (2013). Is extended or continuous infusion of Carbapenems the obvious solution to improve clinical outcomes and reduce mortality? Clinical Infectious Diseases, 57 (2), 324-325. doi:10.1093/cid/cit205
Peer Reviewed verified by ORBi

Moutschen, M., FRIPPIAT, F., CHRISTIAENS, G., & ALLEPAERTS, S. (14 June 2012). HYGIENE ET PROBLEMES INFECTIEUX EN GERIATRIE [Paper presentation]. SOIREES DU MASTER COMPLEMENTAIRE EN GERIATRIE, CHENEE (LIEGE), Belgium.

independent Belgian/Luxembourg Working Party on Antimicrobial Therapy,, MELIN, P., Arendt, V., Cartuyvels, R., Delforge, M.-L., De Waele, J., Delaere, B., FRIPPIAT, F., Hites, M., Ieven, G., Malfroot, A., Konopnicki, D., Pierard, D., Reynders, M., Rossi, C., Tuerlinckx, D., Van Eldere, J., Verhaegen, J., & Vogelaers, D. (2012). Tables 1, 2, 3 and 4 (1-199). In The Sanford Guide to Antimicrobial Therapy 23rd edition of the Belgian/Luxembourg Version 2012-2013 (Adapted for use by the medical profession in Belgium and Luxembourg by the independent Belgian/Luxembourg Working Party on Antimicrobial Therapy (Distributed under license by the Société belge d'infectiologie et de microbiologie clinique SBIMC/BVIKM, pp. 1-500). Sperryville, United States: Jeb C. Sanford - Antimicrobial therapy Inc.
Peer reviewed

LAYIOS, N., LAMBERMONT, B., CANIVET, J.-L., MORIMONT, P., PREISER, J.-C., GARWEG, C., LEDOUX, D., FRIPPIAT, F., PIRET, S., GIOT, J.-B., WIESEN, P., MEURIS, C., MASSION, P., LEONARD, P., NYS, M., LANCELLOTTI, P., CHAPELLE, J.-P., & DAMAS, P. (2012). Procalcitonin usefulness for the initiation of antibiotic treatment in intensive care unit patients. Critical Care Medicine, 40 (8), 2304-9. doi:10.1097/CCM.0b013e318251517a
Peer Reviewed verified by ORBi

Kaux, J.-F., LENELLE, J., FRIPPIAT, F., LE GOFF, C., BARTSCH, V., Crielaard, J.-M., & DIVE, D. (August 2011). Métastase septique dorsale secondaire d’un abcès rétropharyngé responsable d’une tétraparésie. Revue Neurologique, 167 (8-9), 638-640. doi:10.1016/j.neurol.2011.03.001
Peer Reviewed verified by ORBi

Moutschen, P., Bourhaba, M., FRIPPIAT, F., GIOT, J.-B., MEURIS, C., Leonard, P., & Moutschen, M. (2011). A pauci-symptomatic case of documented Hantavirus (Puumala) infection in a patient under anti-TNF treatment. Journal of Clinical Virology, 50 (3), 247-8. doi:10.1016/j.jcv.2010.11.016
Peer Reviewed verified by ORBi

FRIPPIAT, F., & Moutschen, M. (2011). Syphilis treatment in the human immunodeficiency virus-infected patient: follow the guidelines. Clinical Infectious Diseases, 53 (8), 845. doi:10.1093/cid/cir513
Peer Reviewed verified by ORBi

Vanmeerbeek, M., Burette, P., Giet, D., FRIPPIAT, F., & Brunet, S. (16 November 2010). Qu’avons-nous appris de la pandémie de grippe de 2009 ? [Paper presentation]. Enseignement post-universitaire, Liège, Belgium.

Frippiat, F., Bensahi, I., Denooz, R., Charlier, C., Damas, P., & Vanbelle, S. (23 October 2010). Interest of routine dosage of meropenem in difficult to treat infections [Poster presentation]. 48th Annual Meeting of IDSA, Vancouvert, Canada.

ZAOUI, K., MELIN, P., CHRISTIAENS, G., FRIPPIAT, F., & DAMAS, P. (25 June 2010). Antibiotic consumption and bacterial resistance [Paper presentation]. Congrès de la SIZ.

Denooz, R., Frippiat, F., & Charlier, C. (2010). Simultaneous quantification of five Beta-lactam antibiotics in human plasma by HPLC-DAD: Clinical application for ceftazidime treatment in intensive care units. Acta Clinica Belgica, 65 (Suppl. 1), 24-30. doi:10.1179/acb.2010.105
Peer Reviewed verified by ORBi

Mukeba, D., Chandrikakumari, K., Giot, J.-B., Leonard, P., Meuris, C., Frippiat, F., & Moutschen, M. (2009). Autoimmune angioneurotic edema in a patient with Helicobacter pylori infection. Helicobacter, 14 (1), 9-11. doi:10.1111/j.1523-5378.2009.00651.x
Peer Reviewed verified by ORBi

LAYIOS, N., LAMBERMONT, B., LEDOUX, D., MORIMONT, P., MASSION, P., GARWEG, C., FRIPPIAT, F., NYS, M., CHAPELLE, J.-P., & DAMAS, P. (2009). Usefulness of procalcitonin for the decision of antibiotic treatment in ICU patients. Intensive Care Medicine, 35 (Suppl 1), 82.
Peer Reviewed verified by ORBi

Frippiat, F., Chandrikakumari, K., & Moutschen, M. (2009). Gentamicin in infective endocarditis: how to use it? Clinical Infectious Diseases, 49 (2), 320-1; author reply 321. doi:10.1086/600063
Peer Reviewed verified by ORBi

MORIMONT, P., FRIPPIAT, F., LANCELLOTTI, P., & LAMBERMONT, B. (2008). Comment je préviens... l'endocardite infectieuse: Une meilleure hygiène bucco-dentaire plutôt qu'une antibioprophylaxie systématique? Revue Médicale de Liège.
Peer reviewed

Leclercq, P., Frippiat, F., & Lambermont, B. (June 2008). Cotrimoxazole induced mixed type II cryoglobulinemia. European Journal of Internal Medicine, 19 (4). doi:10.1016/j.ejim.2007.09.008
Peer Reviewed verified by ORBi

MORIMONT, P., FRIPPIAT, F., LANCELLOTTI, P., & Lambermont, B. (2008). Comment je previens...l'endocardite infectieuse: une meilleure hygiene bucco-dentaire plutot qu'une antibioprophylaxie systematique? Revue Médicale de Liège, 63 (11), 640-2.
Peer reviewed

Bethlen, S., Chandrikakumari, K., de Leval, L., GIOT, J.-B., Mukeba, D., Leonard, P., Frippiat, F., Meuris, C., Delwaide, J., & Moutschen, M. (2008). Chronic hepatitis C infection in a patient with bone marrow hypoplasia. World Journal of Gastroenterology, 14 (26), 4238-40. doi:10.3748/wjg.14.4238
Peer Reviewed verified by ORBi

Charlier, C., Denooz, R., & Frippiat, F. (2008). Simultaneous determination of five Beta-lactam antibiotics in human plasma by HPLC-DAD: A highly performing approach of the antibiotherapy in intensive care units [Poster presentation]. BelTox, Louvain, Belgium.

Charlier, C., Denooz, R., & FRIPPIAT, F. (2008). Amélioration de la gestion clinique et financière de l'antibiothérapie par le contrôle thérapeutique [Paper presentation]. Séance de Formation Continuée en Biologie Clinique, Liège, Belgium.

Chandrikakumari, K., Giot, J.-B., de Leval, L., Creemers, E., Leonard, P., Mukeba, D., Moutschen, M., & Frippiat, F. (2008). Report of a case of Streptococcus agalactiae mycotic aneurysm and review of the literature. International Journal of Surgical Pathology, 16 (3), 314-9. doi:10.1177/1066896907310304
Peer Reviewed verified by ORBi

Frippiat, F., Chandrikakumari, K., & Moutschen, M. (2008). Decline of antibiotic use in primary care. The Lancet Infectious Diseases, 8 (5), 272; author reply 273. doi:10.1016/S1473-3099(08)70075-6
Peer Reviewed verified by ORBi

Frippiat, F., GIOT, J.-B., Chandrikakumari, K., Leonard, P., Meuris, C., & Moutschen, M. (2008). Syphilis en 2008: controverses et attitudes pratiques. Revue Médicale Suisse, 4 (168), 1823-7.
Peer Reviewed verified by ORBi

Mayasi, N., Chandrikakumari, K., Mukeba, D., GIOT, J.-B., Leonard, P., Hayette, M.-P., Moutschen, M., & Frippiat, F. (01 September 2007). A Patient with Hiv Infection, Cough, Asthenia, and Fever. Clinical Infectious Diseases, 45 (5), 662-3, 559-600. doi:10.1086/520656
Peer Reviewed verified by ORBi

Frippiat, F., Waleffe, A., Soyeur, D., Leonard, P., GIOT, J.-B., & Moutschen, M. (June 2007). Uncomplicated left-sided infective endocarditis due to Escherichia coli, successfully treated with oral levofloxacin. Clinical Research in Cardiology, 96 (6), 401.
Peer Reviewed verified by ORBi

Leclercq, P., Betz, R., Lambermont, B., Leonard, P., & Frippiat, F. (03 February 2007). When the book is wrong. The Lancet, 9559, 369-370. doi:10.1016/S0140-6736(07)60190-1
Peer Reviewed verified by ORBi

Chandrika, K., Dellot, P., Frippiat, F., Giot, J.-B., Leonard, P., Marée, R., Mayasi, N., Meuris, C., Mukeba Tshialala, D., Rahmouni, S., Uurlings, F., Vaira, D., Wehenkel, L., Demonty, J., & Moutschen, M. (2007). Nouvelles approches dans la prise en charge de l'infection a VIH. Revue Médicale de Liège, 62 Spec No, 47-50.
Peer reviewed

Hayette, M.-P., Mukeba Tschialala, D., Meex, C., Frippiat, F., Leonard, P., Huynen, P., Melin, P., & De Mol, P. (2007). Disseminated Penicillium marneffei infection contrated in China [Poster presentation]. 2nd Pan african medical mycology conference PAMMS, Cape Town, South Africa, South Africa.

GIOT, J.-B., Mukeba Tshialala, D., Mayasi Ngongo, N., Frippiat, F., Leonard, P., & Moutschen, M. (2007). Avancees therapeutiques en pathologie infectieuse au cours de la derniere decennie. Revue Médicale de Liège, 62 (5-6, May-Jun), 377-83.
Peer reviewed

Zeddou, M., Rahmouni, S., Vandamme, A., Jacobs, N., Frippiat, F., Leonard, P., SCHAAF-LAFONTAINE, N., Vaira, D., Boniver, J., & Moutschen, M. (2007). Downregulation of CD94/NKG2A inhibitory receptors on CD8+ T cells in HIV infection is more pronounced in subjects with detected viral load than in their aviraemic counterparts. Retrovirology, 4, 72. doi:10.1186/1742-4690-4-72
Peer Reviewed verified by ORBi

Leclercq, P., Loly, C., Giot, J.-B., Frippiat, F., Medart, L., & Malaise, M. (2007). Spondylodiscite compliquée d'un abcès du psoas. Revue Médicale Suisse, 3 (101), 620-621.
Peer Reviewed verified by ORBi

Schrouff, I., VALDES SOCIN, H. G., Frippiat, F., de Leval, L., Soyeur, D., Radermecker, M., & Scheen, A. (2007). Endocardite infectieuse tricuspidienne comme cause d'une fievre d'origine indeterminee. Revue Médicale de Liège, 62 (11), 654-8.
Peer reviewed

Bourhaba, M., GIOT, J.-B., Tshialala, D. M., Leonard, P., Frippiat, F., & Moutschen, M. (2006). L'Hantavirose fait encore parler d'elle. Revue Médicale de Liège, 61 (5-6, May-Jun), 322-8.
Peer reviewed

Contact ORBi